You are here
CP-751871 In Treating Women With Early-Stage Breast Cancer That Can Be Removed By Surgery
About this Study
RATIONALE: Monoclonal antibodies, such as CP-751871, can block tumor growth in different
ways. Some block the ability of tumor cells to grow and spread. Others find tumor cells and
help kill them or carry tumor-killing substances to them.
PURPOSE: This phase I trial is studying the side effects and best way to give CP-751871 in
treating patients with early-stage breast cancer that can be removed by surgery.